Goldman Sachs Group Inc Ideaya Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 816,222 shares of IDYA stock, worth $15.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

816,222

Previous 816,222 -0.0%

Holding current value

$15.9 Million

Previous $13.4 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$16.38 - $26.0 $15.4 Million - $24.5 Million	-941,911 Reduced 53.57%	816,222 $13.4 Million
Q4 2024 Feb 11, 2025	BUY	$24.79 - $31.98 $22 Million - $28.4 Million	888,950 Added 102.27%	1,758,133 $45.2 Million
Q3 2024 Nov 14, 2024	BUY	$30.37 - $43.05 $5.84 Million - $8.28 Million	192,449 Added 28.44%	869,183 $27.5 Million
Q2 2024 Aug 13, 2024	BUY	$34.37 - $43.46 $8.86 Million - $11.2 Million	257,835 Added 61.55%	676,734 $23.8 Million
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $4.81 Million - $6.63 Million	140,733 Added 50.59%	418,899 $18.4 Million
Q4 2023 Feb 13, 2024	SELL	$24.59 - $35.83 $3.49 Million - $5.08 Million	-141,856 Reduced 33.77%	278,166 $9.9 Million
Q3 2023 May 14, 2024	BUY	$21.07 - $29.77 $2.99 Million - $4.22 Million	141,856 Added 51.0%	420,022 $11.3 Million
Q3 2023 Nov 14, 2023	BUY	$21.07 - $29.77 $630,899 - $891,403	29,943 Added 7.68%	420,022 $11.3 Million
Q2 2023 May 14, 2024	BUY	$13.33 - $25.53 $2.64 Million - $5.06 Million	198,350 Added 103.45%	390,079 $9.17 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $2.64 Million - $5.06 Million	198,350 Added 103.45%	390,079 $9.17 Million
Q1 2023 May 14, 2024	BUY	$13.49 - $18.72 $416,814 - $578,410	30,898 Added 19.21%	191,729 $2.63 Million
Q1 2023 May 11, 2023	BUY	$13.49 - $18.72 $416,814 - $578,410	30,898 Added 19.21%	191,729 $2.63 Million
Q4 2022 May 14, 2024	BUY	$14.47 - $18.17 $710,621 - $892,328	49,110 Added 43.96%	160,831 $2.92 Million
Q4 2022 Feb 13, 2023	BUY	$14.47 - $18.17 $710,621 - $892,328	49,110 Added 43.96%	160,831 $2.92 Million
Q3 2022 May 14, 2024	BUY	$9.24 - $15.79 $99,145 - $169,426	10,730 Added 10.62%	111,721 $1.67 Million
Q3 2022 Nov 10, 2022	BUY	$9.24 - $15.79 $99,145 - $169,426	10,730 Added 10.62%	111,721 $1.67 Million
Q2 2022 May 14, 2024	SELL	$8.28 - $13.88 $1.47 Million - $2.46 Million	-177,175 Reduced 63.69%	100,991 $1.39 Million
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $753,446 - $1.26 Million	-90,996 Reduced 47.4%	100,991 $1.39 Million
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $978,048 - $2.1 Million	87,482 Added 83.71%	191,987 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $1.02 Million - $1.31 Million	48,621 Added 87.0%	104,505 $2.47 Million
Q3 2021 Nov 10, 2021	BUY	$17.26 - $27.08 $964,557 - $1.51 Million	55,884 New	55,884 $1.42 Million

Others Institutions Holding IDYA

# of Institutions

213

Shares Held

80.3M

Call Options Held

80.3K

Put Options Held

30.5K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $933M
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Ideaya Biosciences, Inc. Transaction History